Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes

Abstract : Fiber-optic near infrared (NIR) spectroscopy was used to investigate several key features of the polymorphic transitions observed during the crystallization and the filtration of SaC, an Active Pharmaceutical Ingredient (API) produced by Sanofi-Synthelabo. Using few samples, the spectroscopic data were calibrated to provide measurements of the polymorphic composition of the solid product which is likely to appear in two crystalline forms or in the amorphous state. Both qualitative and quantitative methods were successfully evaluated to characterize the API. The NIR spectroscopy measurement was then applied to investigate the kinetic behavior of the phase transition phenomena against various operating conditions. From the viewpoint of industrial process development several applications are presented. The effects of temperature and seed crystal habits on the rate of transition of filtration cakes are briefly investigated; and a study of the effect of residual water in the solvent on the transition occurring during filtration is more deeply analyzed. The experimental results demonstrate that highly valuable information can be provided by the NIR spectroscopy measurements, when one aims at understanding more deeply and optimizing the consequences of various and complex phenomena involved during the solid processing chain.
Type de document :
Article dans une revue
International Journal of Pharmaceutics, Elsevier, 2004, 273 (1-2), pp.159-169. 〈10.1016/j.ijpharm.2004.01.003〉
Liste complète des métadonnées

https://hal-centralesupelec.archives-ouvertes.fr/hal-01270834
Contributeur : Catherine Kruch <>
Soumis le : lundi 8 février 2016 - 15:26:36
Dernière modification le : jeudi 19 avril 2018 - 14:34:08

Identifiants

Collections

Citation

Gilles Fevotte, J. Calas, François Puel, C. Hoff. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes. International Journal of Pharmaceutics, Elsevier, 2004, 273 (1-2), pp.159-169. 〈10.1016/j.ijpharm.2004.01.003〉. 〈hal-01270834〉

Partager

Métriques

Consultations de la notice

51